Introduction
Influenza A Virus, H3N2 Subtype Infections - Overview
Influenza A Virus, H3N2 Subtype Infections - Therapeutics Development
Influenza A Virus, H3N2 Subtype Infections - Therapeutics Assessment
Influenza A Virus, H3N2 Subtype Infections - Companies Involved in Therapeutics Development
Influenza A Virus, H3N2 Subtype Infections - Drug Profiles
Influenza A Virus, H3N2 Subtype Infections - Dormant Projects
Influenza A Virus, H3N2 Subtype Infections - Discontinued Products
Influenza A Virus, H3N2 Subtype Infections - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Influenza A Virus, H3N2 Subtype Infections, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Influenza A Virus, H3N2 Subtype Infections - Pipeline by AbbVie Inc, H1 2020
Influenza A Virus, H3N2 Subtype Infections - Pipeline by Adimmune Corp, H1 2020
Influenza A Virus, H3N2 Subtype Infections - Pipeline by Alla Chem LLC, H1 2020
Influenza A Virus, H3N2 Subtype Infections - Pipeline by Allergy Therapeutics Plc, H1 2020
Influenza A Virus, H3N2 Subtype Infections - Pipeline by Ansun Biopharma Inc, H1 2020
Influenza A Virus, H3N2 Subtype Infections - Pipeline by Aphios Corp, H1 2020
Influenza A Virus, H3N2 Subtype Infections - Dormant Projects, H1 2020
Influenza A Virus, H3N2 Subtype Infections - Dormant Projects, H1 2020 (Contd..1), H1 2020
Influenza A Virus, H3N2 Subtype Infections - Dormant Projects, H1 2020 (Contd..2), H1 2020
Influenza A Virus, H3N2 Subtype Infections - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Influenza A Virus, H3N2 Subtype Infections, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Targets, H1 2020
Number of Products by Stage and Targets, H1 2020
Number of Products by Mechanism of Actions, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020

Companies Mentioned
• AbbVie Inc
• Adimmune Corp
• Alla Chem LLC
• Allergy Therapeutics Plc
• Ansun Biopharma Inc
• Aphios Corp
• Asavi Llc
• AstraZeneca Plc
• AusBio Ltd
• BiondVax Pharmaceuticals Ltd
• BlueWillow Biologics Inc
• Brandenburg Antiinfektiva GmbH
• Changchun Bcht Biotechnology Co Ltd
• Chicago Biosolutions Inc
• Cidara Therapeutics Inc
• Emergent BioSolutions Inc
• FluGen Inc
• Gamma Vaccines Pty Ltd
• i2 Pharmaceuticals Inc
• ILiAD Biotechnologies LLC
• Inovio Pharmaceuticals Inc
• InvVax Inc
• Jiangsu Kanion Pharmaceutical Co Ltd
• Johnson & Johnson
• Medicago Inc
• NanoViricides Inc
• New Amsterdam Sciences Inc
• Novavax Inc
• PrEP Biopharm Ltd
• Sanofi Pasteur SA
• Sciogen Inc
• Seqirus Ltd
• Serum Institute of India Ltd
• Vacthera BioTech GmbH